MAYZENT

Class [005]
Pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of the central nervous system namely central nervous system infections, multiple sclerosis, encephalitis, epilepsy, Alzheimer's, cerebral palsy and Parkinson's disease, brain diseases, central nervous system movement disorders, spinal cord diseases, ocular motility disorders; pharmaceutical preparations for the treatment of psychiatric diseases namely mood, anxiety and cognitive disorders; pharmaceutical preparations for the treatment of urological, urogenital and urinary disorders; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of musculo-skeletal disorders namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, pharmaceutical preparations for the treatment of rheumatism; pharmaceutical preparations for the treatment of diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, dermatitis, skin pigmentation diseases, sexually transmitted diseases, immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes, respiratory diseases, and for anti-inflammatories, anti-infectives, hematological preparations, antibacterials, antivirals, antifungals, anti-cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations, ophthalmological preparations; hormonal preparations for the treatment of pre-menstrual, menopausal and post-menopausal disorders and conditions; vaccines for human use; diagnostic preparations for medical diagnostic use